Clinical trial
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed…
NCT00365274 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00365274 |
|---|---|
| Title | SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma |
| Official title | A Phase II Study of SGN-30 in Combination With CHOP in Anaplastic Large Cell Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anaplastic Large Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Doxorubicin hydrochloride, vincristine sulfate, prednisone, SGN-30 |
| Enrollment | 6 |
| Start date | Aug 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Aug 17, 2006 |
| Last update posted | Jun 2, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: